Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Camden › NPI 1659347920
Hospital

Camden General Hospital, INC.

Camden General Hospital, INC. was paid $3.46M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is 99284, emergency room visit (serious) — 35% of everything it billed.

33Billing provider infoCAMDEN GENERAL HOSPITAL, INC.
CAMDEN, TN 38320
33aNPI1659347920assigned 02/27/2006
33bProvider typeCritical Access Hospital
28Total paid$3.46M
24GClaims54,475
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Tennessee

Rank by total paid#5 of 15
Median peer was paid$1.48M
This provider vs. median2.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official PRESCOTT, TINA controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20186,571$325K
20196,706$357K
20205,084$283K
20216,989$383K
202210,627$613K
20239,680$788K
2024incomplete8,818$714K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 35% 4,408 3,896 $1.21M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 27% 6,162 5,628 $933K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 1,875 1,609 $441K
0202U Oncology (prostate), multianalyte, gene expression profiling 10% 1,511 1,425 $348K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.2% 3,983 3,487 $75K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.0% 6,294 5,170 $71K
80053 Comprehensive metabolic panel 1.6% 4,886 4,118 $54K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.5% 617 580 $52K
71045 Radiologic examination, chest; single view 1.4% 2,238 1,953 $48K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.1% 1,641 1,530 $39K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 1,345 1,159 $29K
36415 Collection of venous blood by venipuncture <1% 7,455 6,112 $23K
36 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 943 $21K
81001 <1% 3,099 $18K
G0378 Hospital observation service, per hour <1% 72 $14K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,060 $12K
83605 <1% 1,361 $11K
84484 <1% 685 $9K
87040 <1% 883 $9K
70450 Computed tomography, head or brain; without contrast material <1% 138 $6K
96375 Therapeutic injection; each additional sequential IV push <1% 393 $6K
80048 Basic metabolic panel (calcium, ionized) <1% 542 $5K
83690 <1% 420 $4K
87430 <1% 296 $4K
71046 Radiologic examination, chest; 2 views <1% 98 $3K
80076 <1% 289 $3K
82150 <1% 329 $3K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 28 $2K
85379 <1% 146 $1K
96361 Intravenous infusion, hydration; each additional hour <1% 62 $1K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 19 $1K
85610 <1% 255 $962.69
85730 <1% 185 $882.43
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 93 $854.94
83880 <1% 76 $811.01
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 34 $714.20
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 28 $564.41
74018 <1% 15 $457.59
83735 <1% 110 $446.14
85027 <1% 72 $401.15
87081 <1% 39 $357.77
81025 <1% 26 $339.42
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 16 $314.92
80305 <1% 16 $204.23
82803 <1% 17 $32.24
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 15 $31.92
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 13 $6.00
A9270 Non-covered item or service 0% 187 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPRESCOTT, TINA (PRESIDENT AND CEO)
Same official

Other billing entities under PRESCOTT, TINA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.